- Research works
- 25 fractional, all time
- Citations
- 1.5k 59.5 per fractional work
- Top-10% rate
- 6.8% record average 16.5%
- Open access
- 46% world 28%
Not ranked overall: Deltagen (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Mathematics, 10.0×. Every wedge is a field page.
Which keywords describe research at Deltagen (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Drug Discovery, Cancer, Therapeutic Targets, Rituximab, Synthesis, Medicinal Chemistry, Inflammation and Prognostic Factors.
- Heterocyclic Compounds
- Anticancer Agents
- Machine Learning
- Biological Evaluation
- Genomic Aberrations
- Prognostic Factors
- Medicinal Chemistry
- Therapeutic Targets
- Drug Discovery
- Cancer
- Inflammation
- Rituximab
- Synthesis
- Chronic Lymphocytic Leukemia
- Molecular Docking
- Heterocycles
- Stem Cells
- Gene Therapy
- Transcriptional Regulation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 19 words, with their numbers
- Cancer3▲ 7.3×12 topics
- Drug Discovery2▲ 25×6 topics
- Inflammation2▲ 4.1×14 topics
- Therapeutic Targets2▲ 41×3 topics
- Rituximab2▲ 55×2 topics
- Medicinal Chemistry2▲ 21×4 topics
- Synthesis2▲ 14×3 topics
- Prognostic Factors2▲ 15×4 topics
- Chronic Lymphocytic Leukemia2▲ 125×1 topic
- Genomic Aberrations2▲ 125×1 topic
- Molecular Docking2▲ 42×2 topics
- Biological Evaluation1▲ 43×2 topics
- Heterocycles1▲ 29×2 topics
- Machine Learning1▲ 2.2×4 topics
- Stem Cells1▲ 14×4 topics
- Anticancer Agents1▲ 16×2 topics
- Gene Therapy1▲ 15×3 topics
- Heterocyclic Compounds1▲ 25×2 topics
- Transcriptional Regulation1▲ 16×4 topics
Which research topics does Deltagen (United States) publish most on?
By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers and Mathematical Biology Tumor Growth.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 4 Mathematical Biology Tumor Growth Modeling and Simulation 0 works
- 5 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 7 Frailty in Older Adults Geriatrics and Gerontology 0 works
- 8 CAR-T cell therapy research Oncology 0 works
- 9 Cancer therapeutics and mechanisms Molecular Biology 0 works
- 10 Lung Cancer Research Studies Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Deltagen (United States)'s research output changed?
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Mateo
- Palo Alto Institute
- Alibaba Group (United States)
- College of San Mateo
- Helix (United States)
- Calabazas Creek Research (United States)
- San Mateo County Health System
- Stottler Henke Associates (United States)
- San Mateo Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.